Copyright Reports & Markets. All rights reserved.

Global Orphan Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Orphan Drugs Market Overview

      • 1.1 Product Overview and Scope of Orphan Drugs
      • 1.2 Orphan Drugs Segment by Type
        • 1.2.1 Global Orphan Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oncology
        • 1.2.3 Gastrointestinal
        • 1.2.4 Pulmonary
        • 1.2.5 Neurology
        • 1.2.6 Hematology
        • 1.2.7 Cardio-vascular
        • 1.2.8 Metabolic disorders
        • 1.2.9 Endocrinology
        • 1.2.10 Infectious diseases
        • 1.2.11 Others
      • 1.3 Orphan Drugs Segment by Application
        • 1.3.1 Orphan Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Speciality Pharmacies
        • 1.3.4 Retail pharmacies
        • 1.3.5 Others
      • 1.4 Global Orphan Drugs Market by Region
        • 1.4.1 Global Orphan Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Orphan Drugs Market Size
        • 1.5.1 Global Orphan Drugs Revenue (2014-2025)
        • 1.5.2 Global Orphan Drugs Production (2014-2025)

      2 Global Orphan Drugs Market Competition by Manufacturers

      • 2.1 Global Orphan Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Orphan Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Orphan Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Orphan Drugs Production Sites, Area Served, Product Types
      • 2.5 Orphan Drugs Market Competitive Situation and Trends
        • 2.5.1 Orphan Drugs Market Concentration Rate
        • 2.5.2 Orphan Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Orphan Drugs Production Market Share by Regions

      • 3.1 Global Orphan Drugs Production Market Share by Regions
      • 3.2 Global Orphan Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Orphan Drugs Production
        • 3.4.1 North America Orphan Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Orphan Drugs Production
        • 3.5.1 Europe Orphan Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Orphan Drugs Production (2014-2019)
        • 3.6.1 China Orphan Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Orphan Drugs Production (2014-2019)
        • 3.7.1 Japan Orphan Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Orphan Drugs Consumption by Regions

      • 4.1 Global Orphan Drugs Consumption by Regions
      • 4.2 North America Orphan Drugs Consumption (2014-2019)
      • 4.3 Europe Orphan Drugs Consumption (2014-2019)
      • 4.4 China Orphan Drugs Consumption (2014-2019)
      • 4.5 Japan Orphan Drugs Consumption (2014-2019)

      5 Global Orphan Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Orphan Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Orphan Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Orphan Drugs Price by Type (2014-2019)
      • 5.4 Global Orphan Drugs Production Growth by Type (2014-2019)

      6 Global Orphan Drugs Market Analysis by Applications

      • 6.1 Global Orphan Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Orphan Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Orphan Drugs Business

      • 7.1 Novartis
        • 7.1.1 Novartis Orphan Drugs Production Sites and Area Served
        • 7.1.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.1.3 Novartis Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Bristol-Myers Squibb
        • 7.2.1 Bristol-Myers Squibb Orphan Drugs Production Sites and Area Served
        • 7.2.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.2.3 Bristol-Myers Squibb Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Celgene
        • 7.3.1 Celgene Orphan Drugs Production Sites and Area Served
        • 7.3.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.3.3 Celgene Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Roche
        • 7.4.1 Roche Orphan Drugs Production Sites and Area Served
        • 7.4.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.4.3 Roche Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Pfizer
        • 7.5.1 Pfizer Orphan Drugs Production Sites and Area Served
        • 7.5.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.5.3 Pfizer Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sanofi
        • 7.6.1 Sanofi Orphan Drugs Production Sites and Area Served
        • 7.6.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.6.3 Sanofi Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Alexion Pharmaceuticals
        • 7.7.1 Alexion Pharmaceuticals Orphan Drugs Production Sites and Area Served
        • 7.7.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.7.3 Alexion Pharmaceuticals Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Eli Lilly
        • 7.8.1 Eli Lilly Orphan Drugs Production Sites and Area Served
        • 7.8.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.8.3 Eli Lilly Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Novo Nordisk
        • 7.9.1 Novo Nordisk Orphan Drugs Production Sites and Area Served
        • 7.9.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.9.3 Novo Nordisk Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 AstraZeneca
        • 7.10.1 AstraZeneca Orphan Drugs Production Sites and Area Served
        • 7.10.2 Orphan Drugs Product Introduction, Application and Specification
        • 7.10.3 AstraZeneca Orphan Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Eisai
      • 7.12 Daiichi Sankyo
      • 7.13 Bayer
      • 7.14 GlaxoSmithKline
      • 7.15 Merck
      • 7.16 Johnson & Johnson
      • 7.17 Biogen
      • 7.18 Shire
      • 7.19 Amgen

      8 Orphan Drugs Manufacturing Cost Analysis

      • 8.1 Orphan Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Orphan Drugs
      • 8.4 Orphan Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Orphan Drugs Distributors List
      • 9.3 Orphan Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Orphan Drugs Market Forecast

      • 11.1 Global Orphan Drugs Production, Revenue Forecast
        • 11.1.1 Global Orphan Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Orphan Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Orphan Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Orphan Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Orphan Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Orphan Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Orphan Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Orphan Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Orphan Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Orphan Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Orphan Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Orphan Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Orphan Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Orphan Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
        High unmet needs are one of the primary drivers of market growth. The need for the development of effective drugs with lesser side-effects is rapidly rising in the market.
        Moreover, the initiatives from the governments of various countries across the globe towards R&D activities and numerous marketing approvals of these drugs have also influenced the orphan drugs market growth. Furthermore, the rising occurrences of rare diseases with the mounting awareness among the population and larger life expectancy numbers have accelerated the global orphan drug market to grow higher.

        The global Orphan Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Orphan Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orphan Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Novartis
        Bristol-Myers Squibb
        Celgene
        Roche
        Pfizer
        Sanofi
        Alexion Pharmaceuticals
        Eli Lilly
        Novo Nordisk
        AstraZeneca
        Eisai
        Daiichi Sankyo
        Bayer
        GlaxoSmithKline
        Merck
        Johnson & Johnson
        Biogen
        Shire
        Amgen

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oncology
        Gastrointestinal
        Pulmonary
        Neurology
        Hematology
        Cardio-vascular
        Metabolic disorders
        Endocrinology
        Infectious diseases
        Others

        Segment by Application
        Hospital Pharmacies
        Speciality Pharmacies
        Retail pharmacies
        Others

        Buy now